- Home
- NVCT vs PUBM Comparison
NVCT vs PUBM Comparison
Compare NVCT & PUBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NVCT | PUBM |
|---|---|---|
| Founded | 2020 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 274.5M | 303.6M |
| IPO Year | 2021 | 2020 |
Fundamental Metrics
Financial Performance| Metric | NVCT | PUBM |
|---|---|---|
| Price | $9.80 | $11.51 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 7 |
| Target Price | $10.00 | ★ $12.43 |
| AVG Volume (30 Days) | 98.5K | ★ 744.0K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $282,926,000.00 |
| Revenue This Year | N/A | $3.44 |
| Revenue Next Year | N/A | $7.86 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.55 | $6.15 |
| 52 Week High | $13.34 | $13.26 |
Technical Indicators
Market Signals| Indicator | NVCT | PUBM |
|---|---|---|
| Relative Strength Index (RSI) | 49.26 | 58.31 |
| Support Level | $8.08 | $7.71 |
| Resistance Level | $9.88 | $12.34 |
| Average True Range (ATR) | 0.54 | 0.54 |
| MACD | -0.15 | -0.00 |
| Stochastic Oscillator | 25.69 | 64.40 |
Price Performance
Historical ComparisonAbout NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.
About PUBM PubMatic Inc.
PubMatic Inc is a supply-side platform provider in the digital advertising technology market. These platforms help publishers, which supply digital ad inventory, manage their inventory, selling a high percentage of their inventory (increase the ad fill rate) and maximizing revenue per ad sold (optimize yield). The company generates revenue mainly by taking a piece of the ad sales that it enables. Buyers on the platform include intermediary buyers, such as demand-side platforms, or advertisers and ad agencies directly. Geographically, the company generates the majority of its revenue from the United States, followed by EMEA and APAC.